본문 바로가기
KERD
논문KCI 등재

The diplotype of UGT1A1 and UGT1A9 genes may predict an increased risk for lung cancer

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Uridine diphosphoglucuronosyltransferases (UGTs) are a superfamily of enzymes that catalyze the glucuronidation of xenobiotics and endobiotics. To reveal occurrence of UGT1A polymorphisms, we retrospectively aimed to characterize UGT1A1-UGT1A9 haplotype structures in Koreans and gain insight on their association with increased cancer incidence. We genotyped UGT1A1 (-3279T>G, -3156G>A, -53(TA)6>7, 211G>A and 686C>A), and UGT1A9 (-2152C>T, -275T>A and -118T9>10) variants by direct sequencing in 98 lung cancer patients and 154 healthy subjects. The haplotype structure across the UGT1A locus was constituted using 4 haplotype-tagging SNPs (htSNPs). For polymorphisms in UGT1A1 and UGT1A9, no significant differences in allele frequency were found between the two groups. The strongest linkage disequilibrium (LD) was discovered between UGT1A1 -53(TA)6>7 and 211G>A, and lowest LD was observed between the UGT1A1 -53(TA)6>7 and UGT1A9 -118T9>10 variant. Eight UGT1A1-UGT1A9 haplotypes were provided and the three most common haplotypes were D-T-6-G, N-T-6-A, and N-G-6-G (73% of all haplotypes) in two groups. Ultimately, no significant differences exist in haplotype frequency between cases and controls (likelihood ratio statistic 20.06, df = 15, p = 0.08). Logistic regression analysis presented a statistically significant association between UGT1A1-UGT1A9 diplotypes including 4 minor alleles and increased lung cancer incidence (OR 31.32, 95% CI 4.34-226.23). There was statistically significant difference in the distribution of the UGT1A1 and UGT1A9 diplotype frequency between cases and controls. These results suggest that the diplotype in the UGT1A1 and UGT1A9 gene might be associated with an increased risk for lung cancer among Korean.

Abstract

Uridine diphosphoglucuronosyltransferases (UGTs) are a superfamily of enzymes that catalyze the glucuronidation of xenobiotics and endobiotics. To reveal occurrence of UGT1A polymorphisms, we retrospectively aimed to characterize UGT1A1-UGT1A9 haplotype structures in Koreans and gain insight on their association with increased cancer incidence. We genotyped UGT1A1 (-3279T>G, -3156G>A, -53(TA)6>7, 211G>A and 686C>A), and UGT1A9 (-2152C>T, -275T>A and -118T9>10) variants by direct sequencing in 98 lung cancer patients and 154 healthy subjects. The haplotype structure across the UGT1A locus was constituted using 4 haplotype-tagging SNPs (htSNPs). For polymorphisms in UGT1A1 and UGT1A9, no significant differences in allele frequency were found between the two groups. The strongest linkage disequilibrium (LD) was discovered between UGT1A1 -53(TA)6>7 and 211G>A, and lowest LD was observed between the UGT1A1 -53(TA)6>7 and UGT1A9 -118T9>10 variant. Eight UGT1A1-UGT1A9 haplotypes were provided and the three most common haplotypes were D-T-6-G, N-T-6-A, and N-G-6-G (73% of all haplotypes) in two groups. Ultimately, no significant differences exist in haplotype frequency between cases and controls (likelihood ratio statistic 20.06, df = 15, p = 0.08). Logistic regression analysis presented a statistically significant association between UGT1A1-UGT1A9 diplotypes including 4 minor alleles and increased lung cancer incidence (OR 31.32, 95% CI 4.34-226.23). There was statistically significant difference in the distribution of the UGT1A1 and UGT1A9 diplotype frequency between cases and controls. These results suggest that the diplotype in the UGT1A1 and UGT1A9 gene might be associated with an increased risk for lung cancer among Korean.

참고문헌 (21)

  1. Paoluzzi L, "Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38", J Clin Pharmacology, 44, pp.854~860 (2004)
  2. Mcgrath M, "Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk", Pharmacogenet Genomics, 19, pp.239~243 (2009)
  3. Dellinger RW, "Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139LYS isoform", Drug Metab Dispos, 34, pp.943~949 (2006)
  4. Guillemette C, "Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans", Cancer Res, 60, pp.950~956 (2000)
  5. Nagar S, "Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer", Oncogene, 25, pp.1659~1672 (2006)
  6. Nagar S, "Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan", Drug Metab Rev, 38, pp.393~409 (2006)
  7. Sandanaraj E, "Influence of UGT1A9 intronic 1399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients", Pharmacogenomics Joural, 8, pp.174~185 (2008)
  8. Guillemette C, "Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels", Cancer Epidemiol Biomarkers Prev, 10, pp.711~714 (2001)
  9. Desai AA, "UGT pharmacogenomics : implications for cancer risk and cancer therapeutics", Pharmacogenetics, 13, pp.517~523 (2003)
  10. Saeki M, "Haplotype structures of the UGT1A gene complex in Japanese population", Pharmacogenomics J, 6, pp.63~75 (2006)
  11. Yamanaka H, "A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity", Pharmacogenetics, 14, pp.329~332 (2004)
  12. Thomas SS, "Genetic variability, haplotypes and htSNPs for exon 1 at the human UGT1A locus", Hum Mutat, 27, pp.717~730 (2006)
  13. Devlin B, "A comparison of linkage disequilibrium measures for fine-scale mapping", Genomics, 29, pp.311~322 (1995)
  14. Zhao JH, "Model-free analysis and permutaion tests for allelic associations", Hum Hered, 50, pp.133~139 (2000)
  15. Innocenti F, "Haplotypes of variants in the UDP-glucuronosyltransferase 1A9 and 1A1 genes", Pharmacogenet Genomics, 15, pp.295~301 (2005)
  16. Adegoke OJ, "Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer", Breast Cancer Res Treat, 85, pp.239~245 (2004)
  17. Tsezou A, "Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women", Genet Test, 11, pp.303~306 (2007)
  18. Huo D, "Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans", Breast Cancer Res Treat, 110, pp.367~376 (2008)
  19. Tang KS, "Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes", World J Gastroenterol, 11, pp.3250~3254 (2005)
  20. Araki J, "Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer", Eur J Cancer, 41, pp.2360~2365 (2005)
  21. Shi X, "CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis", Lung Cancer, 59, pp.155~163 (2008)

관련 논문AI추천

Haplotypes of UGT1A1 and Total Bilirubin Concentration강대룡, 강진형, 김인경, 김정오, 채현석, 최정란한국보건정보통계학회 · 보건정보통계학회지2012 · 제37권 제2호Comprehensive Variant Screening of the UGT Gene Family김영효, 김영훈, 김용하, 김지온, 김해든, 남궁석, 박병래, 신형두, 정면우, 정현섭, 한순영연세대학교의과대학 · Yonsei Medical Journal2014 · 제55권 제1호Genetic Polymorphism of Epoxide Hydrolase and GSTM1 in Lung Cancer Susceptibility of Korean Population김영철, 박경옥, 박종태, Eun Joung Kim, Gye Jung Cho, Jin Young Ju, Jun Hwa Hwang, Kyung Hwa Park, Kyu Sik Kim, Sung Chul Lim, Sung-Ja Ahn, Yu Il Kim대한암학회 · Cancer Research and Treatment2003 · 제35권 제6호Glutathione S-Transferase M1 및 T1과 N-Acetyltransferase 2다형성이 대장암 발생에 미치는 영향김현주, 문선미, 이진경, 장윤환, 정소연, 홍석일, 홍영준, 황대용대한진단검사의학회 · Annals of Laboratory Medicine2005 · 제25권 제6호한국인과 중국 연변지역의 조선족에서 hOGG과 L-myc 그리고 대사효소 등의 다형성과 흡연 및 음주가 폐암발생에 미치는 영향에 대한 비교연구김헌, 강종원, 김용대, 노성일, 엄상용, 이계영, 임동혁, 최강현, 하정호대한임상건강증진학회 · Korean Journal of Health Promotion2006 · 제6권 제2호한국인 췌장암 환자에서 발견한 UGT1A1*37 대립유전자 1예 보고김보연, 김윤정, 김홍경, 이경아대한진단검사의학회 · Laboratory Medicine Online2021 · 제11권 제3호

이 간행물의 다른 논문 (5건)